Preventing the vertical transmission of HIV: Options for resource-rich, resource-limited and resource-poor settings

Tropical Doctor

Volumn 32, Issue 3, 2002, Pages 152-155

  Lyall, E G Hermione ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPED COUNTRY; DEVELOPING COUNTRY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; PRENATAL CARE; RESOURCE MANAGEMENT; REVIEW; RISK FACTOR; VERTICAL TRANSMISSION; VIREMIA; VIRUS LOAD;

DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; PERINATAL CARE; PREGNANCY; PRENATAL CARE; RISK;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036314744     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/004947550203200311     Document Type: Article

References (38)

1. Brossard Y, Aubin JT, Mandelbrot L et al. Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS, 1995;9:359-66.
2. Owens DK, Holodniy M, McDonald TW, Scott J, Sonnad S. A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants. JAMA, 1996;275:1342-8.
3. Chouquet C, Richardson S, Burgard M, Blanche S, Mayaux MJ, Rouzioux C, Costagliola D. Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: bayesian estimation using a mixture. Stat Med, 1999;18:815-33.
4. Ekpini ER, Wiktor SZ, Satten GA et al. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire. Lancet, 1997;349:1054-9.
5. Miotti PG, Taha TE, Kumwenda NI et al. HIV transmission through breastfeeding: a study in Malawi. JAMA, 1999;282:744-9.
6. The European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet, 1992;339:1007-12.
7. Dunn DT, Newell M-L, Ades AE, Peckham C. Estimates of the risk of HIV-1 transmission through breastfeeding. Lancet, 1992;340:585-8.
8. Garcia PM, Kalish LA, Pitt J et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med, 1999;341:394-402.
9. Ghys PD, Fransen K, Kiallo MO et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS, 1997;11:F85-93.
10. The International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. AIDS, 2001;15:357-68.
11. The European Mode of Delivery Collaboration. Elective caesarian-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet, 1999;353:1035-9.
12. The International Perinatal HIV Group. Mode of delivery and vertical transmission of HIV-1: A meta-analysis from fifteen prospective cohort studies. N Engl J Med, 1999;340:977-87.
13. Cliffe S, Tookey PA, Nicoll A. Antenatal detection of HIV: national surveillance and unlinked anonymous survey. BMJ, 2001;323:376-7.
14. WHO briefing notes for UNGASS on HIV/AIDS. In: De Zoysa I, Prevention of mother-to-child transmission of HIV infection, WHO/HIV-AIDS/BN/2001.1. Geneva: WHO, 2001 [www.UNAIDS.org].
15. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med, 1994;331:1173-80.
16. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA, 2001;285:2083-93.
17. Blattner W, Cooper E, Charurat M et al. Effectiveness of potent antiretroviral therapy on reducing perinatal transmission of HIV. The XIII International AIDS Conference, 9-14 July 2000, Durban RSA.
18. Wade NA, Birkhead GS, Warren BL et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med, 1998;339:1409-14.
19. The Antiretroviral Pregnancy Registry (Interim Report) 1 Jan 1989-31 Jul 2000. Wilmington: USA Registry Project Office, 2000.
20. The European Collaborative Study and the Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS, 2000;14:2913-20.
21. Lyall EGH, Blott M, deRuiter A et al. Guidelines for the management of HIV infection in pregnant women and the prevention of mother to child transmission. HIV Med, 2001;2:314-34.
22. Shaffer N, Chuachoowong R, Mock PA et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet, 1999;353:773-80.
23. Lallemant M, Jourdain G, Le Coeur S et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type I. N Engl J Med, 2000;343:982-91.
24. Eastman PS, Shapiro DE, Coombs RW et al. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. J Infect Dis, 1998;177:557-64.
25. Biggar RJ, Miotti PG, Taha TE et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet, 1996;347:1647-50.
26. Taha TE, Biggar RJ, Broadhead RL et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ, 1997;315:216-19, 220.
27. Fawzi WW, Msamanga GI, Hunter D et al. Randomised trial of vitamin supplements in relation to transmission of HIV-1 through breast-feeding and mortality in the first two years of life. The 3rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants 9-13 Sept 2001, Kampala, Uganda [Abstract].
28. Wiktor SV, Ekpini E, Karon JM et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet, 1999;353:781-5.
29. Ditrame ANRS 049 Study Group. 15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. Lancet, 1999;354:2050-1.
30. Gray G. The PETRA study: early and late efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1. The XIII International AIDS Conference, 9-14 July 2000, Durban, RSA (LbOr5).
31. Guay LA, Musoke P, Fleming T et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 1999;354:795-802.
32. Owor M, Deseyve M, Dueifeld C et al. The one year safety and efficacy data of the HIVNET 012 trial. The XIII International AIDS Conference, 9-14 July 2000, Durban, RSA (LbOrl).
33. Mirochnick M, Dorenbaum A, Blanchard S et al. Pre-dose infant nevirapine concentration with the two dose intrapartum-infant NVP regime. The 3rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants, 9-13 Sept 2001, Kampala, Uganda [Abstract].
34. Stringer JSA, Sinkala M, Goldenberg RL et al. A prospective comparison of two strategies for perinatal nevirapine administration in Zambia. The 3rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants, 9-13 Sept 2001, Kampala, Uganda. [Abstract].
35. Nduati R, John G, Mbori-Ngacha D et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomised clinical trial. JAMA, 2000;283:1167-74.
36. Coutsoudis A, Pillay K, Kuhn L, Spooner E, Tsai WY, Coovadia HM. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS, 2001;15:379-87.
37. Nduati R, Mbori-Ngacha D, Kalibala S, Mwai C, Rutenberg N. Breast feeding practice among women who access health care at PMTCT sites in Kenya. The 3rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants, 9-13 Sept 2001, Kampala, Uganda [Abstract].
38. Shetty AK, Winston SW, Coovadia HM, Maldonado Y, Abdool Karim S, Mirochnick M for the HIVNET 023 Study Team. HIVNET 023-a phase 1/11 study of the safety and plasma concentrations of nevirapine given daily, twice weekly, or weekly as HIV prophylaxis in breast feeding infants from birth to 24 weeks in Durban, South Africa and Harare, Zimbabwe. The 3rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants, 9-13 Sept 2001, Kampala, Uganda [Abstract].